Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NeuroGeneration Inc.

Division of Kiadis Pharma Netherlands BV

Latest From NeuroGeneration Inc.

Phase II Can Be a Proof-of-Concept for Management, Too

Obtaining proof-of-concept data is often the key inflection point in the life cycle of a compound. How well a biotech anticipates and plans for the transition from one stage of business to the next may similarly be a critical factor in the company's overall success, according to survey of biotech management practices by Mardis, Aibel & Associates.
BioPharmaceutical Strategy


CeMines has a proprietary method of identifying high volumes of auto-antibody profiles simultaneously; these correlate to regulatory patters in cancer cells, the company believes.

Avalon Pharmaceuticals Inc.

Avalon Pharmaceuticals Inc. hopes to harness the explosion of target information to identify promising drugs without having to rely first on finding new targets. It is employing its target-independent platform to look at the activities of compounds much earlier in the discovery process than conventional screening methods.
BioPharmaceutical Research and Development Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Kiadis Pharma Netherlands BV
  • Senior Management
  • Contact Info
  • NeuroGeneration Inc.
    Phone: (310) 659-6633
    8670 Wilshire Blvd.
    Suite 201
    Los Angeles , CA 90211